{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:07:21Z","timestamp":1790665641303,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s00277-021-04421-2","type":"journal-article","created":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T07:02:44Z","timestamp":1612162964000},"page":"2279-2292","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Positron emission tomography after response to rituximab-CHOP in primary mediastinal large B-cell lymphoma: impact on outcomes and radiotherapy strategies"],"prefix":"10.1007","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8766-1853","authenticated-orcid":false,"given":"Theodoros P.","family":"Vassilakopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sotirios G.","family":"Papageorgiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria K.","family":"Angelopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Chatziioannou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassilios","family":"Prassopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stamatios","family":"Karakatsanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Arapaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zois","family":"Mellios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sotirios","family":"Sachanas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Kalpadakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eirini","family":"Katodritou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theoni","family":"Leonidopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Kotsianidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleftheria","family":"Hatzimichael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Kotsopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Dimou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Variamis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Boutsis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos","family":"Terpos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evridiki","family":"Michali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Karianakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pantelis","family":"Tsirkinidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chryssa","family":"Vadikolia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Poziopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Pigaditou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Effimia","family":"Vrakidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina P.","family":"Siakantaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Christine","family":"Kyrtsonis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Argyris","family":"Symeonidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Anargyrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Papaioannou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evdoxia","family":"Chatziharissi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elissavet","family":"Vervessou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Tsirogianni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Palassopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Gainaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Mainta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Tsirigotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodora","family":"Assimakopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavlina","family":"Konstantinidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Papadaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meletios-Athanassios","family":"Dimopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassiliki","family":"Pappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Themis","family":"Karmiris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paraskevi","family":"Roussou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Datseris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panayiotis","family":"Panayiotidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kostas","family":"Konstantopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerassimos A.","family":"Pangalis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phivi","family":"Rondogianni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,1]]},"reference":[{"key":"4421_CR1","first-page":"175","volume-title":"World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of Haematopoietic and Lympoid Tissues","author":"PM Banks","year":"2001","unstructured":"Banks PM, Warnke RA (2001) Mediastinal (thymic) large B-cell lymphoma. In: Jaffe ES, Harris NL, Stein H, Vardiman JW (eds) World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of Haematopoietic and Lympoid Tissues. IARC Press, Lyon, pp 175\u2013176"},{"key":"4421_CR2","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1634\/theoncologist.11-5-488","volume":"11","author":"KJ Savage","year":"2006","unstructured":"Savage KJ (2006) Primary mediastinal large B-cell lymphoma. Oncologist. 11:488\u2013495","journal-title":"Oncologist."},{"key":"4421_CR3","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/hon.818","volume":"25","author":"E Boleti","year":"2007","unstructured":"Boleti E, Johnson PWM (2007) Primary mediastinal B-cell lymphoma. Hematol Oncol. 25:157\u2013163","journal-title":"Hematol Oncol."},{"key":"4421_CR4","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1093\/annonc\/mdq418","volume":"22","author":"M Rieger","year":"2011","unstructured":"Rieger M, Osterborg A, Pettengell R et al (2011) Primary mediastinal B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: results of the Mabthera International Trial Group study. Ann Oncol. 22:664\u2013670","journal-title":"Ann Oncol."},{"key":"4421_CR5","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1634\/theoncologist.2011-0275","volume":"17","author":"TP Vassilakopoulos","year":"2012","unstructured":"Vassilakopoulos TP, Pangalis GA, Katsigiannis A, Papageorgiou SG, Constantinou N, Terpos E, Zorbala A, Vrakidou E, Repoussis P, Poziopoulos C, Galani Z, Dimopoulou MN, Kokoris SI, Sachanas S, Kalpadakis C, Dimitriadou EM, Siakantaris MP, Kyrtsonis MC, Dervenoulas J, Dimopoulos MA, Meletis J, Roussou P, Panayiotidis P, Beris P, Angelopoulou MK (2012) Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy in primary mediastinal large B-cell lymphoma: The emerging standard of care. Oncologist. 17:239\u2013249","journal-title":"Oncologist."},{"key":"4421_CR6","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1093\/annonc\/mdj030","volume":"17","author":"KJ Savage","year":"2006","unstructured":"Savage KJ, Al-Rajhi N, Voss N et al (2006) Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: the British Columbia experience. Ann Oncol. 17:123\u2013130","journal-title":"Ann Oncol."},{"key":"4421_CR7","doi-asserted-by":"publisher","first-page":"538","DOI":"10.3109\/10428194.2013.810738","volume":"55","author":"JD Soumerai","year":"2014","unstructured":"Soumerai JD, Hellmann MD, Feng Y, Sohani AR, Toomey CE, Barnes JA, Takvorian RW, Neuberg D, Hochberg EP, Abramson JS (2014) Treatment of primary mediastinal B-cell lymphoma with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone is associated with a high rate of primary refractory disease. Leuk Lymphoma. 55:538\u2013543","journal-title":"Leuk Lymphoma."},{"key":"4421_CR8","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3816\/CLM.2009.n.074","volume":"9","author":"PL Zinzani","year":"2009","unstructured":"Zinzani PL, Stefoni V, Finolezzi E, Brusamolino E, Cabras MG, Chiappella A, Salvi F, Rossi A, Broccoli A, Martelli M (2009) Rituximab combined with MACOP-B or VACOP-B and radiation therapy in primary mediastinal large B-cell lymphoma: a retrospective study. Clin Lymphoma Myeloma. 9:381\u2013385","journal-title":"Clin Lymphoma Myeloma."},{"key":"4421_CR9","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1007\/s00277-014-2043-y","volume":"93","author":"A Avigdor","year":"2014","unstructured":"Avigdor A, Sirotkin T, Kedmi M, Ribakovsy E, Berkowicz M, Davidovitz Y, Kneller A, Merkel D, Volchek Y, Davidson T, Goshen E, Apter S, Shimoni A, Ben-Bassat I, Nagler A (2014) The impact of R-VACOP-B and interim FDG-PET\/CT on outcome in primary mediastinal large B cell lymphoma. Ann Hematol. 93:1297\u20131304","journal-title":"Ann Hematol."},{"key":"4421_CR10","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1111\/bjh.14287","volume":"175","author":"M Gleeson","year":"2016","unstructured":"Gleeson M, Hawkes EA, Cunningham D, Chadwick N, Counsell N, Lawrie A, Jack A, Smith P, Mouncey P, Pocock C, Ardeshna KM, Radford J, McMillan A, Davies J, Turner D, Kruger A, Johnson PWM, Gambell J, Linch D (2016) Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP) in the management of primary mediastinal B-cell lymphoma: a subgroup analysis of the UK NCRI R-CHOP 14 versus 21 trial. Br J Haematol. 175:668\u2013672","journal-title":"Br J Haematol."},{"key":"4421_CR11","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1056\/NEJMoa1214561","volume":"368","author":"K Dunleavy","year":"2013","unstructured":"Dunleavy K, Pittaluga S, Maeda LS, Advani R, Chen CC, Hessler J, Steinberg SM, Grant C, Wright G, Varma G, Staudt LM, Jaffe ES, Wilson WH (2013) Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma. N Engl J Med. 368:1408\u20131416","journal-title":"N Engl J Med."},{"issue":"8","key":"4421_CR12","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.3324\/haematol.2018.192492","volume":"103","author":"C Melani","year":"2018","unstructured":"Melani C, Advani R, Roschewski M, Walters KM, Chen CC, Baratto L, Ahlman MA, Miljkovic MD, Steinberg SM, Lam J, Shovlin M, Dunleavy K, Pittaluga S, Jaffe ES, Wilson WH (2018) End-of-treatment and serial PET imaging in primary mediastinal B-cell lymphoma following dose-adjusted EPOCH-R: a paradigm shift in clinical decision making. Haematologica. 103(8):1337\u20131344","journal-title":"Haematologica."},{"issue":"1","key":"4421_CR13","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/leu.2015.120","volume":"30","author":"TP Vassilakopoulos","year":"2016","unstructured":"Vassilakopoulos TP, Pangalis GA, Chatziioannou S, Papageorgiou S, Angelopoulou MK, Galani Z, Kourti G, Prassopoulos V, Leonidopoulou T, Terpos E, Dimopoulou MN, Sachanas S, Kalpadakis C, Konstantinidou P, Boutsis D, Stefanoudaki E, Kyriazopoulou L, Siakantaris MP, Kyrtsonis MC, Variami E, Kotsianidis I, Symeonidis A, Michali E, Katodritou E, Kokkini G, Tsatalas C, Papadaki H, Dimopoulos MA, Sotiropoulos V, Pappa V, Karmiris T, Meletis J, Apostolidis J, Datseris I, Panayiotidis P, Konstantopoulos K, Roussou P, Rondogianni P (2016) PET\/CT in primary mediastinal large B-cell lymphoma responding to rituximab-CHOP: An analysis of 106 patients regarding prognostic significance and implications for subsequent radiotherapy. Leukemia. 30(1):238\u2013242","journal-title":"Leukemia."},{"key":"4421_CR14","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1200\/JCO.2013.51.7524","volume":"32","author":"M Martelli","year":"2014","unstructured":"Martelli M, Ceriani L, Zucca E et al (2014) [18F] fluorodeoxyglucose positron emission tomography predicts survival after chemoimmunotherapy for primary mediastinal large B-cell lymphoma: Results of the International Extranodal Lymphoma Study Group IELSG-26 study. J Clin Oncol 32:1769\u20131775","journal-title":"J Clin Oncol"},{"key":"4421_CR15","doi-asserted-by":"publisher","unstructured":"Hayden A, Tonseth P, Lee DG, et al. Outcome of Primary Mediastinal Large B-cell Lymphoma Using R-CHOP: Impact of a PET Adapted Approach. Blood. 2020; blood.201900429. https:\/\/doi.org\/10.1182\/blood.2019004296. Online ahead of print","DOI":"10.1182\/blood.2019004296"},{"key":"4421_CR16","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/j.1365-2141.2005.05661.x","volume":"130","author":"PA Hamlin","year":"2005","unstructured":"Hamlin PA, Portlock CS, Straus DJ, Noy A, Singer A, Horwitz SM, OConnor OA, Yahalom J, Zelenetz AD, Moskowitz CH (2005) Primary mediastinal large B-cell lymphoma: optimal therapy and prognostic factor analysis in 141 consecutive patients treated at Memorial Sloan Kettering from 1980 to 1999. Br J Haematol. 130:691\u2013699","journal-title":"Br J Haematol."},{"key":"4421_CR17","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1080\/10428190802203788","volume":"49","author":"M Massoud","year":"2008","unstructured":"Massoud M, Koscielny S, Lapusan S, Bosq J, Ribrag V (2008) Primary mediastinal large B-cell lymphomas treated with dose-intensified CHOP alone or CHOP combined with radiotherapy. Leuk Lymphoma. 49:1510\u20131515","journal-title":"Leuk Lymphoma."},{"key":"4421_CR18","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1200\/JCO.1989.7.11.1630","volume":"7","author":"TA Lister","year":"1989","unstructured":"Lister TA, Crowther D, Sutcliffe SB, Glatstein E, Canellos GP, Young RC, Rosenberg SA, Coltman CA, Tubiana M (1989) Report of a Committee to discuss the evaluation and staging of patients with Hodgkin\u2019s disease: Cotswolds Meeting. J Clin Oncol. 7:1630\u20131636","journal-title":"J Clin Oncol."},{"key":"4421_CR19","first-page":"123","volume-title":"Hodgkin Lymphoma","author":"DC Hodgson","year":"2007","unstructured":"Hodgson DC, Gospodarowicz MK (2007) Clinical evaluation and staging of Hodgkin lymphoma. In: Hoppe RT, Mauch PT, Armitage JO, Diehl V, Weiss LM (eds) Hodgkin Lymphoma, 2nd edn. Lippincott Williams & Wilkins, Philadelphia., pp 123\u2013132","edition":"2"},{"key":"4421_CR20","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJM199309303291402","volume":"329","author":"The International non-Hodgkin\u2019s Lymphoma Prognostic Factors Project","year":"1993","unstructured":"The International non-Hodgkin\u2019s Lymphoma Prognostic Factors Project (1993) A predictive model for aggressive non-Hodgkin\u2019s lymphoma. N Engl J Med. 329:987\u2013994","journal-title":"N Engl J Med."},{"key":"4421_CR21","unstructured":"Vassilakopoulos T, Papageorgiou S, Michail M, et al. Prognostic factors (PF) in primary mediastinal large B-cell lymphoma (PMLBCL) treated with rituximab-CHOP (RCHOP) \u00b1 radiotherapy (RT): Identification of very low risk subgroups. EHA Library. 2020; 06\/12\/20; 293713; EP1224"},{"key":"4421_CR22","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1056\/NEJMoa011795","volume":"346","author":"B Coiffier","year":"2002","unstructured":"Coiffier B, Lepage E, Briere J et al (2002) CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large B-cell lymphoma. N Engl J Med. 346:235\u2013242","journal-title":"N Engl J Med."},{"key":"4421_CR23","doi-asserted-by":"publisher","first-page":"5027","DOI":"10.1200\/JCO.2005.09.137","volume":"23","author":"LH Sehn","year":"2005","unstructured":"Sehn LH, Donaldson J, Chhanabhai M, Fitzgerald C, Gill K, Klasa R, MacPherson N, O'Reilly S, Spinelli JJ, Sutherland J, Wilson KS, Gascoyne RD, Connors JM (2005) Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia. J Clin Oncol. 23:5027\u20135033","journal-title":"J Clin Oncol."},{"key":"4421_CR24","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S1470-2045(08)70002-0","volume":"9","author":"M Pfreundschuh","year":"2008","unstructured":"Pfreundschuh M, Schubert J, Ziepert M, Schmits R, Mohren M, Lengfelder E, Reiser M, Nickenig C, Clemens M, Peter N, Bokemeyer C, Eimermacher H, Ho A, Hoffmann M, Mertelsmann R, Tr\u00fcmper L, Balleisen L, Liersch R, Metzner B, Hartmann F, Glass B, Poeschel V, Schmitz N, Ruebe C, Feller AC, Loeffler M, German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL) (2008) Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomized controlled trial (RICOVER-60). Lancet Oncol. 9:105\u2013116","journal-title":"Lancet Oncol."},{"key":"4421_CR25","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","volume":"17","author":"BD Cheson","year":"1999","unstructured":"Cheson BD, Horning SJ, Coiffier B, Shipp MA, Fisher RI, Connors JM, Lister TA, Vose J, Grillo-L\u00f3pez A, Hagenbeek A, Cabanillas F, Klippensten D, Hiddemann W, Castellino R, Harris NL, Armitage JO, Carter W, Hoppe R, Canellos GP (1999) Report of an international workshop to standardize response criteria for non-Hodgkin\u2019s lymphomas. J Clin Oncol. 17:1244\u20131253","journal-title":"J Clin Oncol."},{"key":"4421_CR26","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","volume":"25","author":"BD Cheson","year":"2007","unstructured":"Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ, Coiffier B, Fisher RI, Hagenbeek A, Zucca E, Rosen ST, Stroobants S, Lister TA, Hoppe RT, Dreyling M, Tobinai K, Vose JM, Connors JM, Federico M, Diehl V, International Harmonization Project on Lymphoma (2007) Revised response criteria for malignant lymphoma. J Clin Oncol. 25:579\u2013586","journal-title":"J Clin Oncol."},{"key":"4421_CR27","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1200\/JCO.2006.08.2305","volume":"25","author":"ME Juweid","year":"2007","unstructured":"Juweid ME, Stroobants S, Hoekstra OS, Mottaghy FM, Dietlein M, Guermazi A, Wiseman GA, Kostakoglu L, Scheidhauer K, Buck A, Naumann R, Spaepen K, Hicks RJ, Weber WA, Reske SN, Schwaiger M, Schwartz LH, Zijlstra JM, Siegel BA, Cheson BD (2007) Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. J Clin Oncol. 25:571\u2013578","journal-title":"J Clin Oncol."},{"key":"4421_CR28","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","volume":"32","author":"BD Cheson","year":"2014","unstructured":"Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, Lister TA, Alliance, Australasian Leukaemia and Lymphoma Group, Eastern Cooperative Oncology Group, European Mantle Cell Lymphoma Consortium, Italian Lymphoma Foundation, European Organisation for Research, Treatment of Cancer\/Dutch Hemato-Oncology Group, Grupo Espa\u00f1ol de M\u00e9dula \u00d3sea, German High-Grade Lymphoma Study Group, German Hodgkin's Study Group, Japanese Lymphorra Study Group, Lymphoma Study Association, NCIC Clinical Trials Group, Nordic Lymphoma Study Group, Southwest Oncology Group, United Kingdom National Cancer Research Institute (2014) Recommendations for the initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: The Lugano classification. J Clin Oncol. 32:3059\u20133067","journal-title":"J Clin Oncol."},{"key":"4421_CR29","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1200\/JCO.2013.53.5229","volume":"32","author":"SF Barrington","year":"2014","unstructured":"Barrington SF, Mikhaeel GN, Kostakoglu L et al (2014) Role of imaging in the staging and response assessment of lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol. 32:3048\u20133058","journal-title":"J Clin Oncol."},{"key":"4421_CR30","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"E Kaplan","year":"1958","unstructured":"Kaplan E, Meier P (1958) Non-parametric estimation from incomplete observations. J Am Stat Assoc. 53:457\u2013481","journal-title":"J Am Stat Assoc."},{"key":"4421_CR31","first-page":"163","volume":"50","author":"N Mantel","year":"1966","unstructured":"Mantel N (1966) Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chem Rep. 50:163\u2013170","journal-title":"Cancer Chem Rep."},{"key":"4421_CR32","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.ijrobp.2013.05.053","volume":"87","author":"AR Filippi","year":"2013","unstructured":"Filippi AR, Piva C, Giunta F, Bell\u00f2 M, Chiappella A, Caracciolo D, Zotta M, Douroukas A, Ragona R, Vitolo U, Bisi G, Ricardi U (2013) Radiation therapy in primary mediastinal B-cell lymphoma with positron emission tomography positivity after rituximab chemotherapy. Int J Radiat Oncol Biol Phys. 87:311\u2013316","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"4","key":"4421_CR33","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/hon.2172","volume":"33","author":"PL Zinzani","year":"2015","unstructured":"Zinzani PL, Broccoli A, Casadei B, Stefoni V, Pellegrini C, Gandolfi L, Maglie R, Argnani L, Pileri S, Fanti S (2015) The role of rituximab and positron emission tomography in the treatment of primary mediastinal large B-cell lymphoma: Experience on 74 patients. Hematol Oncol. 33(4):145\u2013150","journal-title":"Hematol Oncol."},{"key":"4421_CR34","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/hon.2012","volume":"31","author":"SG Papageorgiou","year":"2013","unstructured":"Papageorgiou SG, Diamantopoulos P, Levidou G, Angelopoulou MK, Economopoulou P, Efthimiou A, Constantinou N, Katsigiannis A, Korkolopoulou P, Pappa V, Economopoulou C, Georgiou G, Dimou M, Tsirigotis P, Kyrtsonis MC, Kotsianidis I, Kalpadakis C, Dimopoulos MA, Beris P, Meletis J, Pangalis GA, Dervenoulas J, Panayiotidis P, Vassilakopoulos TP (2013) Isolated central nervous system relapses in primary mediastinal large B-cell lymphoma after CHOP-like chemotherapy with or without rituximab. Hematol Oncol. 31:10\u201317","journal-title":"Hematol Oncol."},{"key":"4421_CR35","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/s00277-018-3578-0","volume":"98","author":"A H\u00fcttmann","year":"2019","unstructured":"H\u00fcttmann A, Rekowski J, M\u00fcller SP, Hertenstein B, Franzius C, Mesters R, Weckesser M, Kroschinsky F, Kotzerke J, Ganser A, Bengel FM, la Ros\u00e9e P, Freesmeyer M, H\u00f6ffkes HG, Hertel A, Behringer D, Prange-Krex G, Griesshammer M, Holzinger J, Wilop S, Krohn T, Raghavachar A, Maschmeyer G, Brink I, Schroers R, Gaska T, Bernhard H, Giagounidis A, Sch\u00fctte J, Dienst A, Hautzel H, Naumann R, Klein A, Hahn D, P\u00f6pperl G, Grube M, Marienhagen J, Schwarzer A, Kurch L, H\u00f6hler T, Steiniger H, N\u00fcckel H, S\u00fcdhoff T, R\u00f6mer W, Brinkmann M, Ose C, Alashkar F, Schmitz C, D\u00fcrig J, Hoelzer D, J\u00f6ckel KH, Klapper W, D\u00fchrsen U (2019) Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP: results from the \"Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas\" (PETAL) trial. Ann Hematol. 98:897\u2013907","journal-title":"Ann Hematol."},{"issue":"S1","key":"4421_CR36","first-page":"140","volume":"31","author":"M Martelli","year":"2013","unstructured":"Martelli M, Zucca E, Gospodarowicz M, Johnson PWM, Ricardi U (2013) A randomized, multicentre, two-arm phase III comparative study assessing the role of mediastinal radiotherapy after rituximab-containing chemotherapy regimens to patients with newly diagnosed primary mediastinal large B-cell lymphoma (PMLBCL): The IELSG-37 study. Hematol Oncol 31(S1):140","journal-title":"Hematol Oncol"},{"issue":"1","key":"4421_CR37","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3109\/10428194.2014.929674","volume":"56","author":"TP Vassilakopoulos","year":"2015","unstructured":"Vassilakopoulos TP, Pangalis GA, Polliack A (2015) A \u201cPET\u201d topic in primary mediastinal large B-cell lymphoma: positive or negative, and how to handle it in the end. Leuk Lymphoma. 56(1):3\u20135","journal-title":"Leuk Lymphoma."},{"issue":"1","key":"4421_CR38","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3109\/10428194.2014.910656","volume":"56","author":"CY Cheah","year":"2015","unstructured":"Cheah CY, Hofman MS, Seymour JF, Ritchie DS, Dickinson M, Wirth A, Prince HM, Wolf M, Januszcewicz EH, Carney DA, Herbert KE, Harrison SJ, Burbury KL, Tam CS (2015) The utility and limitations of PET-CT in patients with primary mediastinal B-cell lymphoma: Single institution experience and literature review. Leuk Lymphoma. 56(1):49\u201356","journal-title":"Leuk Lymphoma."},{"issue":"1","key":"4421_CR39","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ijrobp.2015.02.006","volume":"92","author":"CC Pinnix","year":"2015","unstructured":"Pinnix CC, Dabaja B, Ahmed MA, Chuang HH, Costelloe C, Wogan CF, Reed V, Romaguera JE, Neelapu S, Oki Y, Rodriguez MA, Fayad L, Hagemeister FB, Nastoupil L, Turturro F, Fowler N, Fanale MA, Nieto Y, Khouri IF, Ahmed S, Medeiros LJ, Davis RE, Westin J (2015) Single-institution experience in the treatment of primary mediastinal B cell lymphoma treated with immunochemotherapy in the setting of response assessment by 18fluorodeoxyglucose positron emission tomography. Int J Radiat Oncol Biol Phys. 92(1):113\u2013121","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"4","key":"4421_CR40","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.ijrobp.2016.02.057","volume":"95","author":"AR Filippi","year":"2016","unstructured":"Filippi AR, Piva C, Levis M, Chiappella A, Caracciolo D, Bell\u00f2 M, Bisi G, Vitolo U, Ricardi U (2016) Prognostic role of pre-radiation therapy (18)F-fluorodeoxyglucose positron emission tomography for primary mediastinal B-cell lymphomas treated with R-CHOP or R-CHOP-like chemotherapy plus radiation. Int J Radiat Oncol Biol Phys. 95(4):1239\u20131243","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"4421_CR41","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1182\/blood-2016-12-758383","volume":"130","author":"PL Zinzani","year":"2017","unstructured":"Zinzani PL, Ribrag V, Moskowitz CH, Michot JM, Kuruvilla J, Balakumaran A, Zhang Y, Chlosta S, Shipp MA, Armand P (2017) Safety and tolerability of pembrolizumab in patients with relapsed\/refractory primary mediastinal large B-cell lymphoma. Blood. 130:267\u2013270","journal-title":"Blood."},{"issue":"34","key":"4421_CR42","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1200\/JCO.19.01389","volume":"37","author":"P Armand","year":"2019","unstructured":"Armand P, Rodig S, Melnichenko V, Thieblemont C, Bouabdallah K, Tumyan G, \u00d6zcan M, Portino S, Fogliatto L, Caballero MD, Walewski J, Gulbas Z, Ribrag V, Christian B, Perini GF, Salles G, Svoboda J, Zain J, Patel S, Chen PH, Ligon AH, Ouyang J, Neuberg D, Redd R, Chatterjee A, Balakumaran A, Orlowski R, Shipp M, Zinzani PL (2019) Pembrolizumab in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma. J Clin Oncol. 37(34):3291\u20133299","journal-title":"J Clin Oncol."},{"issue":"33","key":"4421_CR43","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1200\/JCO.19.01492","volume":"37","author":"PL Zinzani","year":"2019","unstructured":"Zinzani PL, Santoro A, Gritti G, Brice P, Barr PM, Kuruvilla J, Cunningham D, Kline J, Johnson NA, Mehta-Shah N, Manley T, Francis S, Sharma M, Moskowitz AJ (2019) Nivolumab combined with brentuximab vedotin for relapsed\/refractory primary mediastinal large B-cell lymphoma: Efficacy and safety from the phase II CheckMate 436 study. J Clin Oncol. 37(33):3081\u20133089","journal-title":"J Clin Oncol."}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-021-04421-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-021-04421-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-021-04421-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T06:03:55Z","timestamp":1628661835000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-021-04421-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,1]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["4421"],"URL":"https:\/\/doi.org\/10.1007\/s00277-021-04421-2","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,1]]},"assertion":[{"value":"17 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was waived, since this was a retrospective study, which did not include identifiable personal data or procedures other than those performed during the routine clinical practice.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}